ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Willis reshuffle top team - who is the new MD?

Share On Facebook
share on Linkedin
Print

Who is the new MD of Hughes-Gibb

Willis Group Holdings (NYSE:WSH), the global risk adviser, insurance and reinsurance broker, has “reinforced its position as one of the world’s leading bloodstock insurance brokers” with the appointment today of Sophie Chambers as Managing Director of Hughes-Gibb.

Chambers joins Willis from Lycetts, one of the UK’s market leaders in equine insurance, with their full acquiescence and in an arrangement that heralds much closer collaboration between both firms and their bloodstock businesses.

As part of the deal announced today, Chambers will lead the expansion of Hughes-Gibb, Willis’s specialist bloodstock, livestock and agri-business division, which becomes the exclusive wholesale broker to Lycetts for bloodstock. Two other members of the bloodstock team at Lycetts, Camilla Baker and Ned Barrie, also join Chambers in transferring over to Hughes-Gibb.

A specialist division of Willis, Hughes-Gibb was founded in 1959 as the first broker in London exclusively dedicated to bloodstock insurance, and has expanded to become the only truly global provider of risk management solutions for high-value bloodstock, livestock and agri-businesses.

Commenting on the news, John Muir, who joined Hughes-Gibb in 1989 and is now its Chairman, said: “I’m thrilled to welcome Sophie and her team to the Willis family. Working alongside our dedicated group of bloodstock professionals she will drive our continued expansion in this unique and highly-specialised market, building on our well-established tradition of providing the most innovative and cost-effective risk management solutions and advice.”

Chambers added: “Hughes-Gibb and Lycetts are both significant forces in the bloodstock insurance arena. With its impressive multi-national network, expertise and capabilities, Willis’s Hughes-Gibb is unmatched in thoroughbred insurance globally, while Lycetts is one of the principal players in the UK bloodstock market with an established brand and close-knit customer relationships. By combining our strengths and experience we can offer our respective clients the most intelligent cover and unrivalled service for all their bloodstock insurance needs.”

Angus Keate, Chief Executive Officer of Lycetts, commented: “Our primary concern is to obtain the best cover at the best price for all our clients and we see this as a perfect fit, allowing us to continue providing a highly bespoke personal service to our clients yet benefitting from the leverage of one of the largest brokers in the world.”

CLICK HERE TO REGISTER FOR FREE ON ADVFN, the world's leading stocks and shares information website, provides the private investor with all the latest high-tech trading tools and includes live price data streaming, stock quotes and the option to access 'Level 2' data on all of the world's key exchanges (LSE, NYSE, NASDAQ, Euronext etc).

This area of the ADVFN.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ADVFN Plc. ADVFN Plc does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ADVFN.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ADVFN.COM and is not intended to be relied upon by users in making (or refraining from making) any investment decisions. Authors may or may not have positions in stocks that they are discussing but it should be considered very likely that their opinions are aligned with their trading and that they hold positions in companies, forex, commodities and other instruments they discuss.

Comments are closed

 
Do you want to write for our Newspaper? Get in touch: newspaper@advfn.com